MedTrace Logo

Health Impact of L.Reuteri Consumption in Crew Members of a Naval Ship at Sea

NCT02775019 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2017-05-09

No results posted yet for this study

Summary

This study is designed to evaluate the impact of the regular consumption of probiotic Lactobacillus reuteri-containing lozenges over a period of 42 days on parameters of oral and general health in crew members of a naval ship at sea.

Conditions

  • Gingivitis

Interventions

DIETARY_SUPPLEMENT

Lactobacillus reuteri

2 x daily repeated consumption of a lozenge containing 10E9 CFU Lactobacillus reuteri for 42 days

DIETARY_SUPPLEMENT

Placebo

2 x daily repeated consumption of a lozenge being void of Lactobacillus reuteri for 42 days

Sponsors & Collaborators

  • German Naval Medical Institute

    collaborator OTHER

  • Wuerzburg University Hospital

    lead OTHER

Principal Investigators

  • Ulrich Schlagenhauf, Prof. Dr. · Chairman Dept. of Periodontology, University Hospital Wuerzburg, Germany

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02775019 on ClinicalTrials.gov